Author

Filimon Meichanetzidis

Observed name: Meichanetzidis, Filimon

Institutions: British American Tobacco (United Kingdom), Altasciences Clinical Research Vince & Associates

Observed institutions: British American Tobacco (United Kingdom), Altasciences Clinical Research Vince & Associates

ORCID: 0000-0001-6556-8383

Observed ORCID: 0000-0001-6556-8383

OpenAlex ID: A5075434150

Assessment of biomarkers of exposure and potential harm, and physiological and subjective health measures in exclusive users of nicotine pouches and current, former and never smokers

2022 · David Azzopardi, Linsey E. Haswell, et al. · Biomarkers · 38

Biomarkers of exposure and potential harm in exclusive users of electronic cigarettes and current, former, and never smokers

2023 · Linsey E. Haswell, Nathan Gale, et al. · Internal and Emergency Medicine · 14

Biomarkers of Exposure and Potential Harm in Exclusive Users of Nicotine Pouches and Current, Former, and Never Smokers: Protocol for a Cross-sectional Clinical Study

2022 · David Azzopardi, Linsey Ellen Haswell, et al. · JMIR Research Protocols · 10

A Randomized Crossover Clinical Study to Assess the Effect of Oral Nicotine Pouches Used for Different Durations on Plasma Nicotine Pharmacokinetics in Healthy Oral Pouch Consumers

2025 · David Azzopardi, Elaine Brown, et al. · The Journal of Clinical Pharmacology · 9

Plasma Nicotine Pharmacokinetics of Oral Nicotine Pouches Across Varying Flavours and Nicotine Content *

2023 · Michael McEwan, Linsey Ellen Haswell, et al. · Contributions to Tobacco & Nicotine Research · 5

Works count: 6

Citation count: 76

H-index: 5

I10-index: 3